Skip to main
TERN
TERN logo

Terns Pharmaceuticals (TERN) Market Capitalization Overview

Market Cap: $338.88M as of Jun 13, 2025

$338.88M
Past Month+$96.08M (39.57%)
As of Jun 13, 2025, Terns Pharmaceuticals (TERN) has a market capitalization of $338.88M. Over the past 30 days, its market cap has decreased by -7.82%, while in the last 12 months, it has decreased by -27.99%.

Market capitalization represents the total value of Terns Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Terns Pharmaceuticals (TERN) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Terns Pharmaceuticals (TERN) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Terns Pharmaceuticals (TERN) Market Cap History

DateMarket CapChange
Jun 2, 2025$286.47M-7.82%
May 1, 2025$310.78M+39.06%
Apr 1, 2025$223.49M-22.39%
Mar 3, 2025$287.95M-22.43%
Feb 3, 2025$371.19M-22.93%
Jan 2, 2025$481.61M-7.80%

Terns Pharmaceuticals (TERN) End of Year Market Cap History

DateMarket CapChange
2025$338.88M-27.99%
2024$470.57M+17.33%
2023$401.05M-17.86%
2022$488.28M+174.81%
2021$177.68M

FAQs About Terns Pharmaceuticals (TERN) Market Cap

As of Jun 13, 2025, the market capitalization of Terns Pharmaceuticals (TERN) is $338.88M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Terns Pharmaceuticals’s market capitalization has increased by 39.57%, changing from $242.80M to $338.88M as of Jun 13, 2025.

In the last 3 months, Terns Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Terns Pharmaceuticals’s market capitalization increased from $401.05M in January to $470.57M in December, reflecting a 17.33% change.

In the past five years, Terns Pharmaceuticals (TERN) has had a compound annual growth rate (CAGR) of 27.57% in market capitalization. This means its market cap has grown at an average rate of 27.57% per year.

Terns Pharmaceuticals (TERN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.